Search Results

You are looking at 171 - 180 of 1,601 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies

Jeremy P. Harris, Mehr Kashyap, Jessi N. Humphreys, Daniel T. Chang, and Erqi L. Pollom

additional treatments. Demographic and Clinical Characteristics Using data from the SEER registry, we determined age, sex, race, Hispanic ethnicity, marital status, area income, cancer stage, and disease subsite. 13 Dual Medicaid insurance and Charlson

Full access

Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000–2017

Nina N. Sanford, David J. Sher, Xiaohan Xu, Chul Ahn, Anthony V. D’Amico, Ayal A. Aizer, and Brandon A. Mahal

Southwestern Medical Center deemed the study exempt given the use of public deidentified data. Statistical Analysis Baseline Characteristics Baseline characteristics, including demographic and socioeconomic variables, were reported for the entire cohort (N=34

Full access

Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study

Chengwei Peng, Saad Saffo, Paul E. Oberstein, Michael Shusterman, Charlene Thomas, Daniel J. Becker, Jordan D. Berlin, Lawrence P. Leichman, Ben Boursi, Anil B. Nagar, and Shun Yu

hazards method. Survival curves for time-to-event variables were estimated using the Kaplan-Meier method. A propensity score was generated to account for any imbalances in baseline characteristics between the 2 study groups. All baseline covariates

Full access

Methylene Blue for the Treatment of Intractable Pain From Oral Mucositis Related to Cancer Treatment: An Uncontrolled Cohort

Carlos J. Roldan, Matthew Chung, Lei Feng, and Eduardo Bruera

.4 (SAS Institute Inc.) and Splus 8.2 (TIBCO Software Inc) were used for all analyses. Results Patient Characteristics We identified 350 adult patients who were prescribed MB oral rinse for oral pain from mucositis related to cancer therapy

Full access

CLO24-060: Organomegalies as a Predictive Indicator of Leukemia Cutis in the Patients With Acute Myeloid Leukemia

Chalothorn Wannaphut, Chanakarn Kanitthamniyom, Penvadee Pattanaprichakul, Smith Kungwankiatichai, and Weerapat Owattanapanich

Leukemia cutis (LC) is an extramedullary acute myeloid leukemia (AML) infiltrate. No research has outlined the clinical characteristics and outcomes of Thai patients diagnosed with AML who exhibit LC. We conducted a 7-year retrospective case

Full access

Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level

Vinayak Muralidhar, Paul L. Nguyen, Brandon A. Mahal, David D. Yang, Kent W. Mouw, Brent S. Rose, Clair J. Beard, Jason A. Efstathiou, Neil E. Martin, Martin T. King, and Peter F. Orio III

PSA levels ≥98.0 ng/mL are grouped together without further granularity regarding the exact PSA level. Median age and follow-up were compared using the Kruskal-Wallis test; other baseline patient characteristics were compared using the chi-square test

Full access

Role of Postoperative Radiotherapy in Nonmetastatic Head and Neck Adenoid Cystic Carcinoma

Yue Chen, Zi-Qi Zheng, Fo-Ping Chen, Jian-Ye Yan, Xiao-Dan Huang, Feng Li, Ying Sun, and Guan-Qun Zhou

the role of PORT in survival outcome, which would help surgeons and radiologists provide individualized recommendations regarding PORT to patients with ACC. Patients and Methods Patient Characteristics From January 2000 through December 2017, 480

Full access

Cachexia and Dietetic Interventions in Patients With Esophagogastric Cancer: A Multicenter Cohort Study

Willemieke P.M. Dijksterhuis, Anouk E.J. Latenstein, Jessy Joy van Kleef, Rob H.A. Verhoeven, Jeanne H.M. de Vries, Marije Slingerland, Elles Steenhagen, Joos Heisterkamp, Liesbeth M. Timmermans, Marian A.E. de van der Schueren, Martijn G.H. van Oijen, Sandra Beijer, and Hanneke W.M. van Laarhoven

is provided by the patient. 27 Data on patient and tumor characteristics, treatment, and survival were extracted from the Netherlands Cancer Registry (NCR), which is a population-based registry that covers the total Dutch population of >17 million

Full access

Association of Medicaid Expansion With Timely Receipt of Treatment and Survival Among Patients With HR-Negative, HER2-Positive Breast Cancer

Kewei Sylvia Shi, Xu Ji, Changchuan Jiang, Kathryn J. Ruddy, Sharon M. Castellino, K. Robin Yabroff, and Xuesong Han

-concordant treatment (surgery/chemotherapy/targeted therapy) and was categorized into <30 days, <60 days, and <90 days from cancer diagnosis. The following socioeconomic, demographic, and clinical characteristics are shown in the descriptive table: age group at

Full access

A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m2 for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Matthew G. Fury, Eric Sherman, Donna Lisa, Neeraj Agarwal, Kenneth Algazy, Bruce Brockstein, Corey Langer, Dean Lim, Ranee Mehra, Sandeep K. Rajan, Susan Korte, Brynna Lipson, Furhan Yunus, Tawee Tanvetyanon, Stephanie Smith-Marrone, Kenneth Ng, Han Xiao, Sofia Haque, and David G. Pfister

more of the first 18 patients (each group treated separately) experienced a dose-limiting toxicity (as defined in the protocol) during cycle 1 or 2, that group would be closed because of excess toxicity. Results Patient Characteristics The